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Objectives To determine the impact of novel invitation strategies on population participation in
faecal immunochemical test (FIT)-based colorectal cancer (CRC) screening.
Setting A community screening programme in Adelaide, South Australia.
Methods In total, 2400 people aged 50–74 years were randomly allocated to one of four CRC
screening invitation strategies: (a) Control: standard invitation-to-screen letter explaining risk of CRC
and the concept, value and method of screening; (b) Risk: invitation with additional messages related
to CRC risk; (c) Advocacy: invitation with additional messages related to advocacy for screening from
previous screening programme participants and (d) Advance Notification: first, a letter introducing
Control letter messages followed by the standard invitation-to-screen. Invitations included an FIT kit.
Programme participation rates were determined for each strategy relative to control. Associations
between participation and sociodemographic variables were explored.
Results At 12 weeks after invitation, participation was: Control: 237/600 (39.5%); Risk: 242/600
(40.3%); Advocacy: 216/600 (36.0%) and Advance Notification: 290/600 (48.3%). Participation
was significantly greater than Control only in the Advance Notification group (Relative risk [RR] 1.23,
95% confidence interval [CI] 1.06–1.43). This effect was apparent as early as two weeks from date of
offer; Advance Notification: 151/600 (25.2%) versus Control: 109/600 (18.2%, RR 1.38, 95% CI
1.11–1.73).
Conclusions Advance notification significantly increased screening participation. The effect may be
due to a population shift in readiness to undertake screening, and is consistent with the Transtheoretical
Model of behaviour change. Risk or lay advocacy strategies did not improve screening participation.




opulation screening by guaiac faecal occult blood
testing (FOBT) reduces mortality from colorectal
cancer (CRC)1–3 and reduces incidence of CRC
through removal of colorectal adenomas.4 FOBTs are ideally
suited for population screening for CRC because screening
can be implemented through the postal system. Therefore,
effective print-based communication between screening
providers and programme invitees is crucial for high levels
of uptake, although few studies have investigated the direct
impact of alternative invitation strategies on screening
programme participation.
Actual participation rates in FOBT-based population
screening5 have been well below the estimated 75% for
whom FOBT-based screening is medically appropriate.6 In
studies exploring ways to improve participation in FOBT-
based screening, we identified three strategies that had the
potential to improve programme uptake over a standard
invitation: (1) Enhanced awareness of CRC risk; (2)
Advocacy for screening and (3) Advance notification of
invitation.
Enhanced awareness of risk for CRC
Perceptions of risk and vulnerability are powerful determi-
nants of participation in screening, although the effect may
be modulated by how risk is expressed.7 Perceived risk for
CRC has previously been shown to influence uptake in
FOBT screening,8 and an improved understanding of
personal risk is associated with uptake of mammography
screening.9
Advocacy for screening
Celebrity advocacy has been shown to promote uptake of
health programmes, including cancer screening,10 but the
strategy suffers from being opportunistic and often has only
temporary effects.11 General practitioner advocacy for
screening improved uptake among patients,12 but can be
difficult to apply on a population scale. However, statements
supporting screening from individuals of similar age and
outlook to programme invitees, especially from those with
previous successful screening outcomes, could enhance
uptake of screening.
Advance notification of invitation
Previous FOBT screening trials have used the strategy of
sending an advance notification letter alerting recipients
that an invitation to screen for CRC will soon follow.13–17
While most studies showed that this was associated with
increased uptake, it was often administered together with
educational materials and so the effect alone is unclear.
Advance notification has never been trialled in programmes
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using faecal immunochemical tests (FIT) where several
barriers to participation are reduced.11
The aim of this study was to determine the impact of three
novel letter-based invitation-to-screen strategies on partici-




A standard invitation letter containing health-related
messages concerning CRC prevention and the value and
ease of screening.
Risk
An invitation containing the standard invitation messages,
plus additional positively framed messages about CRC risk,
generalized risk for CRC and relative risk for CRC.
Advocacy
An invitation containing the standard invitation messages,
plus messages from ‘like’ others advocating CRC screening.
Colour photographs of the lay advocates (one male,
one female) and personal endorsement statements were
included.
Advanced notification
First, an Advance Notification letter introducing standard
invitation messages, followed in two weeks by the standard
(Control group) invitation.
Study population
Invitees were selected from the electoral roll of the
Australian Electoral Commission (AEC). The extract con-
sisted of the names and addresses of 24,905 people aged
50–74 years on 29 October 2004 from nine postcode areas.
In all, 2400 people were randomly selected and allocated to
Control, Risk, Advocacy and Advance Notification groups.
Screening implementation
Between 17 January and 7 April 2005, those selected were
mailed an offer of FIT screening from a central screening
facility located within a public hospital. The offer included
an invitation letter, study information, an InSures FIT kit
(Enterix Australia Inc.) and a reply paid envelope. All
invitation letters were single page printed on hospital
letterhead. Invitees were sent a reminder letter at six weeks
from invitation if required. FIT sample cards were developed
by an accredited pathology laboratory. All test positive
participants were encouraged to complete colonoscopy
follow-up.
Outcomemeasures
The primary outcome was participation in screening,
defined as the return of a completed sample card within
12 weeks from the date screening offers were posted.
Secondary outcomes were participation at two weeks from
the date invitations were mailed (early participation), and
participation at 14 weeks from first contact, defined as
14 weeks from date of mailing the first print-based
communication.
Other data
The AEC supplied age (as 5-year band), sex and suburb in
addition to name and street address data. Knowledge of
suburb allows the index of relative socioeconomic disad-
vantage (IoSED, Australian Bureau of Statistics) to be
determined. Disadvantaged areas have low IoSED values.
Statistical analyses
FIT sample card returns were monitored for 14 weeks from
the date the screening invitation was sent. Intervention
groups were similar for proportions of sex, age band and
IoSED. Unadjusted comparisons of participation by group
and sociodemographic variables were undertaken using
univariate generalized linear models (GLM). Comparisons
of participation by group adjusted for sociodemographic
variables were undertaken using multivariate GLM. Cluster-
ing by suburb was adjusted for in all models. All analyses
were undertaken using the statistical software STATA 8
(StataCorp).
RESULTS
Impact of invitation strategy on participation
The Advance Notification group had a significantly in-
creased participation rate compared with the Control group
at week 12 (univariate GLM relative risk (RR)¼ 1.23, 95%
confidence interval [CI] 1.06–1.43). The same pattern was
seen at week 2 with an even stronger relationship (Advance
Notification: 151/600 [25.2%] versus Control: 109/600
(18.2%), RR 1.38, 95% CI 1.11–1.73). Adjusting for sex,
age group and IoSED provided similar results for week 12,
but reduced the impact of Advanced Notification at week
2. The Risk and Advocacy strategies failed to increase
participation relative to the Control (Week 12 results: Risk;
242 sample cards returned/600, 40.3% participation rate,
Advocacy; 216/600, 36.0%).
Adjustment for 2-week difference in programme
awareness
The Advance Notification group had had an extra two
weeks’ awareness about the screening programme at week
12 compared with the Control group, which may have
contributed to their better overall participation. We there-
fore compared participation at 14 weeks from first contact,
where participation was: Control 238/600, 39.7%; Advance
Notification 290/600, 48.3%, unadjusted and adjusted
RR¼ 1.22, 95% CI 1.05–1.42).
Associations with participation
Age was associated with participation at both week 12 (age
band 60–64 years: RR 1.32, CI 1.12–1.56; 65–69 years: RR
1.47, CI 1.23–1.77) and week 2 (60–64 years: RR 1.50, CI
1.13–2.01, 65–69 years: RR 1.76, CI 1.36–2.27). Being female
was associated with participation at week 12 (RR 1.13, CI
1.03–1.26). IoSED was weakly associated with participation
at week 12 (P¼ 0.067) with more advantaged suburbs
having higher participation.
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DISCUSSION
These results demonstrate that a simple advance notification
letter had a significant and positive effect on participation
in FIT-based CRC screening. The effect was large and
immediate. In contrast, two other interventions were
ineffective in promoting participation levels above that of
a standard invitation letter.
Advance notification letters were used in early trials of
guaiac FOBT screening.14–17 However, those studies failed to
show a consistent increase in participation, perhaps because
advance notification letters were accompanied by educa-
tional material or the effect was masked by other barriers to
participation associated with guaiac FOBTs. Using an
advance notification letter with low information burden,
coupled with removal of diet and medication barriers
through the use of immunochemical tests, may allow the
positive effect of advance notification to become evident.
The difference in participation between the Advance
Notification and Control groups was not due to lead-time
bias because, when participation was monitored for 14
weeks from initial contact, the difference in participation
between Control and Advance Notification groups remained
constant and significant.
Early gains in knowledge of the magnitude, risk and
curability of CRC due to the advance notification letter,
reinforced by similar information in the standard invitation
letter, may be responsible for the immediate effect of this
strategy. This is of importance to screening programme
planning, where the test return pattern determines remin-
der letter and test development workloads. A rapid response
to a screening invitation, following an advance notification
letter, at least partly, balances an overall increase in
programme postage costs due to reduced reminder costs.
It is unclear why invitations that included risk and
advocacy messages failed to improve participation. To
ensure that additional messages did not adversely influence
the comprehension level, we kept the simple measure of
gobbledegook scores18 to within one grade level. However, it
is possible that slightly increased length of the risk and
advocacy invitations may have contributed to information
burden, negating any effect on participation. The Advance
Notification group received an invitation letter identical to
the Control group and would not have been affected by
information burden.
In univariate analyses, we demonstrated associations
between participation at 12 weeks and 2 weeks and age, and
between participation at 12 weeks and being female. The
strongest association was between participation at two weeks
and being aged 65–69 years. Low uptake in the youngest age
band is likely to be due to perceived lack of time and low
perceived risk. Developing interventions to specifically improve
participation in the younger age bands should be a priority.
Health behaviour change models, such as the Trans-
theoretical Model (TTM) and its variants, propose that
health behaviours follow a ‘stages of change’ pathway.19
Our findings are consistent with the TTM and support the
notion that an advance notification letter moves people
from being unaware of CRC or CRC screening to being
aware, or from being aware to contemplation of action, so
that when an actual offer of screening that includes a
screening test is made, it is only a small step further to
complete the required behaviour.
These results highlight the potential benefit of a simple
advance notification letter in population-based CRC screen-
ing programmes.
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